Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data

Abstract

This study compared long-term population-based survival outcomes of preoperative and postoperative radiotherapy (RT) approaches in rectal cancer. Patients with stage II-III rectal cancer between 1998 and 2013 were identified using the Surveillance, Epidemiology, and End Results database. Overall survival (OS) and disease-specific survival (DSS) rates were estimated in propensity-matched study population according to the use of RT. Among the 28,320 eligible patients, a total of 18,400 patients were identified from propensity score matching process balancing the distribution of prognostic covariates. The 10-year OS and DSS rates were higher in patients with preoperative RT than the postoperative group (51.6% vs. 49.8% with P < 0.001, and 65.4% vs. 64.8% with P = 0.037, respectively). However, in multivariate analysis, selection of combined RT sequence did not affect the survival (hazard ratio [HR] 1.04 and 95% confidence interval [CI] 0.98−1.10 for OS; HR 0.97 and 95% CI 0.90−1.05 for DSS). Regarding hazard rate functions of cancer-specific mortality, the overall time-course risks after preoperative and postoperative RT were comparable. This study provides additional insight into the long-term prognostic implications of the two RT strategies, suggesting that the sequence of RT does not lead to differential survival in stage II-III rectal cancer.

The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer

“…Additionally, high CRP was also significantly associated with poor outcomes, including malnutrition, a high inflammatory state, advanced tumor stage, and poorer performance status. CRP is a classical acute-phase response protein, the production of which is closely linked to inflammatory stimulation of hepatocytes and macrophages 26 . It is rapidly elevated during acute inflammatory responses.…”

Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis

“…In retrospective cohort studies, treatment-related selection bias resulting from an imbalance in the baseline characteristics is inevitable ( 29 ). Propensity score matching (PSM) can reduce the selection bias, offset differing clinical features among groups, and bolster the evidence of a retrospective cohort study ( 30 ).…”